T regulatory cells as a potential therapeutic target in psychosis?: current challenges and future perspectives (2021)
- Authors:
- USP affiliated authors: LOUZADA JÚNIOR, PAULO - FMRP ; BEN, CRISTINA MARTA DEL - FMRP ; ZUELLI, FABIANA MARIA DAS GRAÇAS CORSI - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.bbih.2021.100330
- Subjects: SISTEMA IMUNE; IMUNOLOGIA; TRANSTORNOS PSICÓTICOS; ESQUIZOFRENIA
- Keywords: Adaptive immune system; FoxP3; Interleukin-6; Psychosis; Regulatory T cells; Schizophrenia; Tregs
- Language: Inglês
- Imprenta:
- Source:
- Título: Brain, Behavior, & Immunity - Health
- ISSN: 2666-3546
- Volume/Número/Paginação/Ano: v. 17, art. 100330, p. 1-14, 2021
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
ZUELLI, Fabiana Maria das Graças Corsi et al. T regulatory cells as a potential therapeutic target in psychosis?: current challenges and future perspectives. Brain, Behavior, & Immunity - Health, v. 17, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bbih.2021.100330. Acesso em: 01 abr. 2026. -
APA
Zuelli, F. M. das G. C., Deakin, B., Lima, M. H. F. de, Qureshi, O., Barnes, N. M., Upthegrove, R., et al. (2021). T regulatory cells as a potential therapeutic target in psychosis?: current challenges and future perspectives. Brain, Behavior, & Immunity - Health, 17, 1-14. doi:10.1016/j.bbih.2021.100330 -
NLM
Zuelli FM das GC, Deakin B, Lima MHF de, Qureshi O, Barnes NM, Upthegrove R, Louzada Júnior P, Del-Ben CM. T regulatory cells as a potential therapeutic target in psychosis?: current challenges and future perspectives [Internet]. Brain, Behavior, & Immunity - Health. 2021 ; 17 1-14.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.bbih.2021.100330 -
Vancouver
Zuelli FM das GC, Deakin B, Lima MHF de, Qureshi O, Barnes NM, Upthegrove R, Louzada Júnior P, Del-Ben CM. T regulatory cells as a potential therapeutic target in psychosis?: current challenges and future perspectives [Internet]. Brain, Behavior, & Immunity - Health. 2021 ; 17 1-14.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.bbih.2021.100330 - Antinuclear antibodies testing as a routine screening for systemic lupus erythematosus in patients presenting first-episode psychosis
- Quantification of the serum levels of NR1 and NR2 NMDA receptor in patients in the first episode psychosis
- Uso de maconha (Cannabis sativa) e perfil inflamatório em pacientes em primeiro episódio psicótico e controles de base populacional
- Parvalbumin (PVALB) promoter dna methylation association with early-life trauma in first episode psychosis patients
- Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment
- The relationship of childhood trauma and DNA methylation of NMDA receptor genes in first-episode schizophrenia
- The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis
- Signals of adaptive immune activation in non-clinical populations with psychotic experiences
- State and trait inflammatory markers and the psychosis continuum model
- Plasma prevalence of anti-N-methyl-d-aspartate receptor IgG antibodies in early stages of psychosis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003251218.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
